Byung-Ki Cho

Amministratore Delegato presso BIONOTE, INC.

Patrimonio netto: 1 M $ in data 30/04/2024

56 anni

Health Technology

Profilo

Byung-Ki Cho is currently the Chief Executive Officer & Director at BioNote, Inc. He previously worked as the Director & Head-Research Center at Abbott Diagnostics Korea, Inc.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
SD BIOSENSOR, INC. 0.12%	28/03/2024	150 000 ( 0.12% )	1 M $	30/04/2024

Posizioni attive di Byung-Ki Cho

Società	Posizione	Inizio
BIONOTE, INC.	Amministratore Delegato	01/08/2020

Tutte le posizioni attive di Byung-Ki Cho

Precedenti posizioni note di Byung-Ki Cho

Società	Posizione	Fine
Abbott Diagnostics Korea, Inc. Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Byung-Ki Cho

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Byung-Ki Cho

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BIONOTE, INC.	Health Technology

Aziende private	1
Abbott Diagnostics Korea, Inc. Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea.	Health Technology